Latest articles
No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.
Sentiment statistics ?
Financial Histories
Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.
Overview
1498.HKDay performance
| 1498.HK | |
|---|---|
| Price | 0.94 |
| Change Pct | 4.44 |
| Change Abs | 0.04 |
| Market Cap | 371.3 million |
| Eps | -0.30 |
| Pe Ratio | -3.13 |
| Outstanding Shares | 395.1 million |
| Volume | 10000 |
| Avg Volume | 135491 |
| Industry | Drug Manufacturers—Specialty & Generic |
| Sector Name | Health Care |
| Country Short Name | HK |
| Announcement Earnings | 2023-08-29 00:00:00+00:00 |
Dividends
There is no dividend data to display. Refer our Dividend calendar for other accurate data.
Risk Profiles
Please sign up and become a member to view all risk profiles.
Peers
The peer analysis is for none of your tickers available
Focus
Use our 'Focus' approach as text-and chart based summaries of the financial standing for a company. They are solely focussing on the company's market, risks and chances.
Company descriptions
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names.